Literature DB >> 25816259

Radiobiology of tissue reactions.

W Dörr1.   

Abstract

Tissue effects of radiation exposure are observed in virtually all normal tissues, with interactions when several organs are involved. Early reactions occur in turnover tissues, where proliferative impairment results in hypoplasia; late reactions, based on combined parenchymal, vascular, and connective tissue changes, result in loss of function within the exposed volume; consequential late effects develop through interactions between early and late effects in the same organ; and very late effects are dominated by vascular sequelae. Invariably, involvement of the immune system is observed. Importantly, latent times of late effects are inversely dependent on the biologically equieffective dose. Each tissue component and--importantly--each individual symptom/endpoint displays a specific dose-effect relationship. Equieffective doses are modulated by exposure conditions: in particular, dose-rate reduction--down to chronic levels--and dose fractionation impact on late responding tissues, while overall exposure time predominantly affects early (and consequential late) reactions. Consequences of partial organ exposure are related to tissue architecture. In 'tubular' organs (gastrointestinal tract, but also vasculature), punctual exposure affects function in downstream compartments. In 'parallel' organs, such as liver or lungs, only exposure of a significant (organ-dependent) fraction of the total volume results in clinical consequences. Forthcoming studies must address biomarkers of the individual risk for tissue reactions, and strategies to prevent/mitigate tissue effects after exposure. © The International Society for Prosthetics and Orthotics Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Biomarker; Dose fractionation; Dose rate; Intervention; Radiopathology; Repopulation; Tissue reactions; Volume effect

Mesh:

Year:  2015        PMID: 25816259     DOI: 10.1177/0146645314560686

Source DB:  PubMed          Journal:  Ann ICRP        ISSN: 0146-6453


  14 in total

1.  Why RBE must be a variable and not a constant in proton therapy.

Authors:  Bleddyn Jones
Journal:  Br J Radiol       Date:  2016-07       Impact factor: 3.039

Review 2.  Pelvic insufficiency fracture (PIF) incidence in patients treated with intensity-modulated radiation therapy (IMRT) for gynaecological or anal cancer: single-institution experience and review of the literature.

Authors:  Louis Bazire; Haoping Xu; Jean-Philippe Foy; Malika Amessis; Caroline Malhaire; Kim Cao; Anne De La Rochefordiere; Youlia M Kirova
Journal:  Br J Radiol       Date:  2017-03-14       Impact factor: 3.039

3.  Factors Affecting Oncologic Outcomes of 90Y Radioembolization of Heavily Pre-Treated Patients With Colon Cancer Liver Metastases.

Authors:  Ieva Kurilova; Regina G H Beets-Tan; Jessica Flynn; Mithat Gönen; Gary Ulaner; Elena N Petre; F Edward Boas; Etay Ziv; Hooman Yarmohammadi; Elisabeth G Klompenhouwer; Andrea Cercek; Nancy A Kemeny; Constantinos T Sofocleous
Journal:  Clin Colorectal Cancer       Date:  2018-09-13       Impact factor: 4.481

Review 4.  Chronic radiation proctitis: tricks to prevent and treat.

Authors:  Ben G L Vanneste; Lien Van De Voorde; Rogier J de Ridder; Evert J Van Limbergen; Philippe Lambin; Emile N van Lin
Journal:  Int J Colorectal Dis       Date:  2015-07-23       Impact factor: 2.571

5.  The radiation safety education and the pain physicians' efforts to reduce radiation exposure.

Authors:  Tae Hee Kim; Seung Wan Hong; Nam Sik Woo; Hae Kyoung Kim; Jae Hun Kim
Journal:  Korean J Pain       Date:  2017-03-31

6.  The Effect of Protracted Exposure to Radiation on Liver Injury: A Cohort Study of Industrial Radiographers in Xinjiang, China.

Authors:  Qing Sun; Weiming Mao; Haiyue Jiang; Xiaoyue Zhang; Jing Xiao; Yulong Lian
Journal:  Int J Environ Res Public Health       Date:  2018-01-04       Impact factor: 3.390

7.  Protective effects of systemic dermatan sulfate treatment in a preclinical model of radiation-induced oral mucositis.

Authors:  Sylvia Gruber; Katharina Frings; Peter Kuess; Wolfgang Dörr
Journal:  Strahlenther Onkol       Date:  2018-03-01       Impact factor: 3.621

8.  Soft Tissue Necrosis in Head and Neck Cancer Patients After Transoral Robotic Surgery or Wide Excision With Primary Closure Followed by Radiation Therapy.

Authors:  Yun Hee Lee; Yeon Sil Kim; Mi Joo Chung; Mina Yu; So Lyung Jung; Ie Ryung Yoo; Youn Soo Lee; Min Sik Kim; Dong Il Sun; Jin Hyung Kang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

9.  Heparin treatment mitigates radiation-induced oral mucositis in mice by interplaying with repopulation processes.

Authors:  M Kowaliuk; I Schröder; P Kuess; W Dörr
Journal:  Strahlenther Onkol       Date:  2019-01-28       Impact factor: 3.621

10.  Effects of topical polydeoxyribonucleotide on radiation-induced oral mucositis.

Authors:  Anna M Podlesko; Nicola Ramacciati; Serenella Panzolini; Simonetta Saldi; Serenella Fiorucci; Daniela Pierini; Marina Mancini; Maria S Merolla; Valentina Lancellotta; Cynthia Aristei
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2018-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.